Unicycive Therapeutics Joins Russell Microcap® Index
July 01, 2024 07:03 ET
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
Quantum Computing Inc. Announces Inclusion in Russell Microcap Index
June 28, 2022 08:35 ET
|
Quantum Computing Inc.
LEESBURG, Va., June 28, 2022 (GLOBE NEWSWIRE) -- Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT) a leader in accessible quantum computing, has joined the Russell Microcap® Index,...
ProPhase Labs Added to the Russell Microcap Index
June 28, 2021 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, June 28, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”), a diversified medical science and technology company, today announces that it has...
CareCloud a Member of Russell Microcap Index
June 22, 2021 09:15 ET
|
CareCloud, Inc
SOMERSET, N.J., June 22, 2021 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company” or “CareCloud”) (Nasdaq: MTBC) (Nasdaq: MTBCP), a leader in healthcare technology solutions for medical practices and...
SINTX Technologies Achieves Placement on the Russell Microcap Index
June 09, 2021 09:00 ET
|
SINTX Technologies, Inc.
SALT LAKE CITY, UT, June 09, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) (www.sintx.com), an original equipment manufacturer (OEM) of silicon nitride...
Monaker Group Joins Russell Microcap Index
July 01, 2019 09:00 ET
|
Monaker Group, Inc
WESTON, FL, July 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Monaker Group, Inc. (Nasdaq: MKGI), a technology leader in the travel and vacation rental markets, has been added to the Russell...
Liquidia Technologies Added to Russell 2000®, 3000® and Microcap® Indexes
September 24, 2018 08:00 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq:LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company focused on the development...